HCA Healthcare, Inc. (HCA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 7B 14B 21B Q4 '14: 9.6B Q1 '15: 9.7B Q2 '15: 9.9B Q1 '17: 10.6B Q2 '17: 10.7B Q3 '17: 10.7B Q4 '17: 11.6B Q1 '18: 11.4B Q2 '18: 11.5B Q3 '18: 11.5B Q4 '18: 12.3B Q1 '19: 12.5B Q2 '19: 12.6B Q3 '19: 12.7B Q4 '19: 13.5B Q1 '20: 12.9B Q2 '20: 11.1B Q3 '20: 13.3B Q4 '20: 14.3B Q1 '21: 14B Q2 '21: 14.4B Q3 '21: 15.3B Q4 '21: 15.1B Q1 '22: 14.9B Q2 '22: 14.8B Q3 '22: 15B Q4 '22: 15.5B Q1 '23: 15.6B Q2 '23: 15.9B Q3 '23: 16.2B Q4 '23: 17.3B Q1 '24: 17.3B Q2 '24: 17.5B Q3 '24: 17.5B Q4 '24: 18.3B Q1 '25: 18.3B Q2 '25: 18.6B Q3 '25: 19.2B Q4 '25: 19.5B Q1 '26: 19.1B Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income Quarterly

0 800M 1.6B 2.4B Q2 '16: 658M Q3 '16: 618M Q4 '16: 920M Q1 '17: 659M Q2 '17: 657M Q3 '17: 426M Q4 '17: 474M Q1 '18: 1.1B Q2 '18: 820M Q3 '18: 759M Q4 '18: 1.1B Q1 '19: 1B Q2 '19: 783M Q3 '19: 612M Q4 '19: 1.1B Q1 '20: 581M Q2 '20: 1.1B Q3 '20: 668M Q4 '20: 1.4B Q1 '21: 1.4B Q2 '21: 1.4B Q3 '21: 2.3B Q4 '21: 1.8B Q1 '22: 1.3B Q2 '22: 1.2B Q3 '22: 1.1B Q4 '22: 2.1B Q1 '23: 1.4B Q2 '23: 1.2B Q3 '23: 1.1B Q4 '23: 1.6B Q1 '24: 1.6B Q2 '24: 1.5B Q3 '24: 1.3B Q4 '24: 1.4B Q1 '25: 1.6B Q2 '25: 1.7B Q3 '25: 1.6B Q4 '25: 1.9B Q1 '26: 1.6B Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

0 3B 6B 9B Q1 '16: 1.4B Q2 '16: 1.3B Q3 '16: 1.2B Q4 '16: 1.7B Q1 '17: 1.3B Q2 '17: 1.4B Q3 '17: 1B Q4 '17: 1.7B Q1 '18: 1.3B Q2 '18: 1.6B Q3 '18: 1.7B Q4 '18: 2.2B Q1 '19: 974M Q2 '19: 2B Q3 '19: 2.1B Q4 '19: 2.5B Q1 '20: 1.4B Q2 '20: 8.7B Q3 '20: 2.7B Q1 '21: 2B Q2 '21: 2.3B Q3 '21: 2.3B Q4 '21: 2.4B Q1 '22: 1.3B Q2 '22: 1.6B Q3 '22: 3B Q4 '22: 2.5B Q1 '23: 1.8B Q2 '23: 2.5B Q3 '23: 2.5B Q4 '23: 2.7B Q1 '24: 2.5B Q2 '24: 2B Q3 '24: 3.5B Q4 '24: 2.6B Q1 '25: 1.7B Q2 '25: 4.2B Q3 '25: 4.4B Q4 '25: 2.4B Q1 '26: 2B Q1 '17 Q2 '18 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Free Cash Flow Quarterly

0 3B 6B 9B Q1 '16: 890M Q2 '16: 686M Q3 '16: 494M Q4 '16: 823M Q1 '17: 709M Q2 '17: 671M Q3 '17: 279M Q4 '17: 752M Q1 '18: 589M Q2 '18: 702M Q3 '18: 875M Q4 '18: 1B Q1 '19: 193M Q2 '19: 1B Q3 '19: 987M Q4 '19: 1.2B Q1 '20: 522M Q2 '20: 8B Q3 '20: 2.2B Q1 '21: 1.3B Q2 '21: 1.4B Q3 '21: 1.4B Q4 '21: 1.3B Q1 '22: 484M Q2 '22: 550M Q3 '22: 1.9B Q4 '22: 1.2B Q1 '23: 606M Q2 '23: 1.2B Q3 '23: 1.3B Q4 '23: 1.5B Q1 '24: 1.4B Q2 '24: 690M Q3 '24: 2.3B Q4 '24: 1.3B Q1 '25: 660M Q2 '25: 3B Q3 '25: 3.1B Q4 '25: 870M Q1 '26: 895M Q1 '17 Q2 '18 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 200M 400M 600M Q1 '13: 462.4M Q2 '13: 463.2M Q3 '13: 463.6M Q1 '14: 457.4M Q2 '14: 453M Q3 '14: 447.3M Q1 '15: 435.3M Q2 '15: 429.4M Q3 '15: 426.4M Q1 '16: 410.6M Q2 '16: 398.7M Q3 '16: 389.6M Q1 '17: 380M Q2 '17: 375.3M Q3 '17: 369.8M Q1 '18: 359.7M Q2 '18: 355M Q3 '18: 353.6M Q1 '19: 350.3M Q2 '19: 348.4M Q3 '19: 347.5M Q1 '20: 344.1M Q2 '20: 341.6M Q3 '20: 343.3M Q1 '21: 343.3M Q2 '21: 332.6M Q3 '21: 324M Q1 '22: 307.4M Q2 '22: 296.1M Q3 '22: 289.9M Q1 '23: 281M Q2 '23: 278.2M Q3 '23: 275.4M Q1 '24: 268M Q2 '24: 264.1M Q3 '24: 259.9M Q1 '25: 249.4M Q2 '25: 241.9M Q3 '25: 236.2M Q1 '26: 226.7M Q2 '14 Q1 '16 Q3 '17 Q2 '19 Q1 '21 Q3 '22 Q2 '24 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 10.00 20.00 30.00 Q2 '16: 5.79 Q3 '16: 6.33 Q4 '16: 7.32 Q1 '17: 7.37 Q2 '17: 7.47 Q3 '17: 7.03 Q4 '17: 5.94 Q1 '18: 7.38 Q2 '18: 7.94 Q3 '18: 8.94 Q4 '18: 10.65 Q1 '19: 10.44 Q2 '19: 10.38 Q3 '19: 9.99 Q4 '19: 10.07 Q1 '20: 8.79 Q2 '20: 9.70 Q3 '20: 9.89 Q4 '20: 10.94 Q1 '21: 13.39 Q2 '21: 14.59 Q3 '21: 19.64 Q4 '21: 21.23 Q1 '22: 21.23 Q2 '22: 20.77 Q3 '22: 17.68 Q4 '22: 19.13 Q1 '23: 19.84 Q2 '23: 20.23 Q3 '23: 20.23 Q4 '23: 18.95 Q1 '24: 20.03 Q2 '24: 21.27 Q3 '24: 22.24 Q4 '24: 21.97 Q1 '25: 22.49 Q2 '25: 23.79 Q3 '25: 25.87 Q4 '25: 28.34 Q1 '26: 29.04 Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.